Department of Neurosurgery, K.E.M. Hospital and Seth G.S. Medical College, Parel, Mumbai, India.
J Neurosurg. 2010 Jun;112(6):1341-6. doi: 10.3171/2009.11.JNS091083.
The management issues of 106 cases of pituitary tumors with a fluid level within the fluid content of the cystic part of the tumor (a "fluid-fluid" level) were reviewed.
Between 2000 and March 2009, 1660 pituitary tumors were treated neurosurgically at K.E.M. Hospital. Investigations of 106 of these cases revealed a fluid-fluid level within the tumor. All patients underwent surgery via a transsphenoidal route. The mean follow-up duration was 46 months.
The tumors varied in size: 31 were between 1 and 3 cm, and 75 were larger than 3 cm in maximum dimension (mean maximum dimension 3.4 cm). Fifty-two tumors had 1 fluid level, 11 had 2, and 43 had multiple fluid levels (> or = 3). The onset of symptoms was acute in 8 cases and insidious in 98 cases. In 16 cases, there was evidence of acute exacerbation of symptoms during the course of symptom progression. The symptoms were progressive in all cases. Ninety-seven percent of patients had visual deficits at the time of presentation. The solid portion of the tumor was relatively friable and vascular in most cases, and the fluid varied in color and in consistency, from a thin yellow to dark red liquid. Visual outcome was extremely gratifying in the majority of cases; of those presenting with visual dysfunction, 94% reported visual recovery in the immediate postoperative period. During the follow-up period, there was tumor recurrence in 21 cases; in 12 of these cases, the authors documented a fluid-fluid level. The histological features did not indicate malignancy in any case.
A fluid level within a fluid cavity in pituitary tumors is rarely reported but is not uncommon in large/giant tumors. The presence of such a feature suggests that surgery in these cases can be relatively straightforward despite the lesion's large size, and the visual outcome is gratifying. However, recurrence rates are relatively higher in such cases than in other pituitary tumors.
回顾分析 106 例瘤内存在液性成分(囊性部分)的垂体瘤(“液-液”水平)的管理问题。
2000 年至 2009 年 3 月期间,K.E.M.医院对 1660 例垂体瘤患者进行了神经外科治疗。对其中 106 例患者的调查显示肿瘤内存在液-液水平。所有患者均经蝶窦入路进行手术。平均随访时间为 46 个月。
肿瘤大小不一:31 例肿瘤直径为 1-3cm,75 例肿瘤直径大于 3cm(最大直径平均为 3.4cm)。52 例肿瘤有 1 个液平,11 例肿瘤有 2 个液平,43 例肿瘤有多个液平(≥3 个)。8 例患者症状起病急,98 例患者症状起病隐匿。在 16 例患者中,症状进展过程中出现症状急剧恶化的证据。所有患者的症状均进行性加重。97%的患者就诊时存在视力缺损。大多数情况下,肿瘤实性部分相对脆弱且富含血管,而液体的颜色和稠度不一,从稀薄的黄色到暗红色不等。大多数情况下,视力结果非常令人满意;在存在视力障碍的患者中,94%的患者在术后即刻报告视力恢复。在随访期间,有 21 例患者发生肿瘤复发;在这 21 例患者中,作者记录到 12 例存在液-液水平。在任何情况下,组织学特征均未提示恶性肿瘤。
在垂体瘤的液性腔中存在液平罕见但并非罕见于大/巨大肿瘤。存在这种特征表明,尽管病变较大,手术相对简单,且视力结果令人满意,但这些病例的复发率相对较高。